Regulations.gov document

Exhibit 12 - "Guidance for Industry Genotoxic and Carcinogenic Impurities in Drug…

Supporting & Related Material · FDA-2009-P-0289 · posted Jun 29, 2009

Key facts

Document ID FDA-2009-P-0289-0009
Title Exhibit 12 - "Guidance for Industry Genotoxic and Carcinogenic Impurities in Drug Substances and Products: Recommended Approaches, December 2008" - [Reckitt Benckiser Pharmaceuticals Inc. (RBP) - Citizen Petition] re FDA-2009-P-0289-0001]
Document type Supporting & Related Material
Subtype CP-Citizen Petition (Supporting & Related Materials)
Agency FDA
Docket FDA-2009-P-0289
Posted Jun 29, 2009

At a glance

  • None Public comments on this docket

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Regulations.gov documents

Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.

Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date:

Browse all Regulations.gov documents